PACS Raises 2026 EBITDA Guidance to $685M-$695M on 33.6% Q3 EBITDA Growth
PACS has more than doubled off its 52-week low of $10.31.
Summary
PACS posted Q3 revenue of $1.50 billion (+11.5%) and Adjusted EBITDA of $175.7 million (+33.6%), then raised 2026 Adjusted EBITDA guidance to $685M-$695M and closed its Florida and Texas acquisitions.
Key Events · Earnings and Guidance · PACS
-
Q3 Revenue Up 11.5% to $1.50B
Revenue was $1.50 billion versus $1.34 billion a year ago; net income rose 16.2% to $60.8 million and diluted EPS was $0.37.
-
Adjusted EBITDA Jumps 33.6%
Adjusted EBITDA reached $175.7 million, up $44.2 million from $131.5 million, with Adjusted EPS of $0.63 (+37.0%).
-
2026 EBITDA Guidance Raised
Full-year 2026 Adjusted EBITDA guidance lifted to $685M-$695M from $640M-$660M, and revenue guidance to $5.95B-$6.05B from $5.75B-$5.85B.
-
Florida and Texas Deals Closed
All 32 Florida facilities closed October 1, 2026, and all 11 Texas facilities closed as of November 1, 2026; portfolio now spans 398 operations in 21 states.
Analysis · PACS · Industrial Applications And Services
PACS beat its own trajectory: Q3 revenue rose 11.5% to $1.50 billion while Adjusted EBITDA jumped 33.6% to $175.7 million, and management lifted full-year 2026 Adjusted EBITDA guidance to $685M-$695M from $640M-$660M (about 37% growth at the midpoint). Revenue guidance moved up to $5.95B-$6.05B. The company also closed both pending deals — all 32 Florida facilities on October 1 and 11 Texas facilities by November 1 — so the growth pipeline is now in the numbers rather than a promise. With net leverage at 0.2x and $707.4 million of liquidity, the balance sheet supports more acquisitions. The offset: stock-based compensation nearly quadrupled to $45.3 million this quarter, and the previously disclosed DOJ/SEC investigations and material weaknesses remain unresolved overhangs.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PACS was trading at $46.68 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.4B. The 52-week trading range was $10.31 to $50.38. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.